Home › Ulcerative Colitis
Pag-aaral pangklinika para sa Ulcerative Colitis na nagre-recruit sa U.S.
81 pag-aaral para sa Ulcerative Colitis ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- New York City, NY24 pag-aaral
- Orlando, FL23 pag-aaral
- Miami, FL22 pag-aaral
- Houston, TX18 pag-aaral
- San Antonio, TX16 pag-aaral
- San Diego, CA16 pag-aaral
- Tacoma, WA15 pag-aaral
- Chicago, IL15 pag-aaral
- Tyler, TX14 pag-aaral
- St. Louis, MO14 pag-aaral
- Colorado Springs, CO14 pag-aaral
- Los Angeles, CA13 pag-aaral
- Washington, DC12 pag-aaral
- Boston, MA12 pag-aaral
- Durham, NC11 pag-aaral
- Cincinnati, OH11 pag-aaral
- Providence, RI11 pag-aaral
- Louisville, KY10 pag-aaral
- Lewisville, TX10 pag-aaral
- Parma, OH10 pag-aaral
- Tampa, FL10 pag-aaral
- Evanston, IL9 pag-aaral
- Lubbock, TX9 pag-aaral
- Atlanta, GA9 pag-aaral
- Mountain View, CA8 pag-aaral
- Cleveland, OH8 pag-aaral
- Scottsdale, AZ8 pag-aaral
- Metairie, LA8 pag-aaral
- Memphis, TN8 pag-aaral
- Round Rock, TX8 pag-aaral
- Garland, TX8 pag-aaral
- Lancaster, CA8 pag-aaral
- Baltimore, MD8 pag-aaral
- Seattle, WA8 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Waukegan, IL7 pag-aaral
- Dallas, TX7 pag-aaral
- Dayton, OH7 pag-aaral
- Charlotte, NC7 pag-aaral
- Anaheim, CA7 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona19 pag-aaral
- Arkansas4 pag-aaral
- California41 pag-aaral
- Colorado17 pag-aaral
- Connecticut11 pag-aaral
- District of Columbia3 pag-aaral
- Florida32 pag-aaral
- Georgia15 pag-aaral
- Idaho4 pag-aaral
- Illinois24 pag-aaral
- Indiana9 pag-aaral
- Iowa3 pag-aaral
- Kansas10 pag-aaral
- Kentucky13 pag-aaral
- Louisiana15 pag-aaral
- Maryland13 pag-aaral
- Massachusetts17 pag-aaral
- Michigan17 pag-aaral
- Minnesota8 pag-aaral
- Mississippi6 pag-aaral
- Missouri17 pag-aaral
- Nevada6 pag-aaral
- New Hampshire5 pag-aaral
- New Jersey7 pag-aaral
- New York31 pag-aaral
- North Carolina24 pag-aaral
- Ohio26 pag-aaral
- Oklahoma4 pag-aaral
- Oregon5 pag-aaral
- Pennsylvania13 pag-aaral
- Rhode Island11 pag-aaral
- South Carolina12 pag-aaral
- South Dakota4 pag-aaral
- Tennessee12 pag-aaral
- Texas34 pag-aaral
- Utah8 pag-aaral
- Virginia14 pag-aaral
- Washington22 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07845487Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07697456Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07619547A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06619990A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06979336A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07463183Immune Regulation in Ulcerative Colitis or Crohn s Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Day – 75 Years · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Nagre-recruitPhase 3
Edad 3 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Nagre-recruitPhase 2/3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07415044LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Nagre-recruitPhase 3
Edad 2 hanggang 19 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Nagre-recruitPhase 3
Edad 2 hanggang 17 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07071519Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07513181A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Nagre-recruitPhase 4
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
Edad 16 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07185009A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06581328Microbiome-targeted Diet Therapy in Ulcerative Colitis
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07520461Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07501078Confirmatory Clinical Study in Active Ulcerative Colitis
Nagre-recruitPhase 2
Edad 16 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07296315Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.